Vireo Systems launches NSAID alternative for dogs
MADISON, Tenn. — Vireo Systems on Thursday launched CanineActiv, a pain reliever for dogs that will serve as an alternative to NSAIDs. "We have had outstanding success with NSAID alternatives for people, and we knew that many of our discoveries and innovations could be extended to dogs," Mark Faulkner, Vireo Systems president said. "With CanineActiv, consumers can expect the same level of safe and effective pain relief for their dogs as they’ve come to expect for themselves from AminoActiv."
CanineActiv will be available in two formulations, a safe, non-toxic pain reliever and a version for high-performance breeds. The pain reliever contains an anti-inflammatory ingredient, Alpha-GEE, along with a special formulation of homeopathic compounds for dogs. Alpha-GEE is a unique compound made up of naturally occurring amino acids found in natural sources, the company noted.
The high-performance breeds product, also known as CanineActiv HP, was created with sporting and working dogs in mind, such as hunting dogs, police K-9 units and service dogs. With fall and winter hunting seasons on the horizon, many of these dedicated helpers will spend hours slogging through cold marshland and wilderness, a perfect recipe for fatigue and achy bones and joints. CanineActiv HP promotes endurance, mobility and recovery from intense exercise. The capsules can also be given as a preventative measure before such activity.
The Vireo Systems online store is now home to both AminoActiv and CanineActiv. However, the company is seeking retail distribution.
PGT Healthcare, Swisse Wellness collaborate on global VMS brand
MELBOURNE, Australia — PGT Healthcare, the international joint venture between Procter & Gamble and Teva Pharmaceutical Industries, earlier this week announced a collaboration with Swisse Wellness, a leading wellness brand in Australia, to begin expanding Swisse Wellness’ range of more than 100 vitamins, minerals and supplements globally over the next few years.
Swisse Wellness products are currently available in Australia, New Zealand and the United States. The collaboration with PGT Healthcare encompasses all new markets in Europe, Asia and Latin America.
The new licensing deal will help create a new global "megabrand," the companies stated. The synergies derived from a global focus include a deeper understanding of consumer shopper behavior, marketing scale advantages and global regulatory and go-to-market expertise.
W.Va. Retailers Association lauds efforts to prevent diversion of OTC drugs for meth
CHARLESTON, W.Va. — Through mid-November, a national registry of over-the-counter drugs considered chemical precursors to methamphetamine prevented more than 16,700 boxes of the drugs from being sold illegally.
The West Virginia Retailers Association heralded data showing that the National Precursor Log Exchange or NPLEx prevented the sale of about 16,753 boxes from being sold illegally, thus preventing more than 44,400 g from potentially being diverted to making meth. The congestion drug pseudoephedrine is a common ingredient in many OTC products for cold and allergies, but also is a key ingredient in the making of meth. Earlier this month, according to published reports, Rite Aid decided to stop selling OTC products that contain pseudoephedrine as their only active ingredient, though it would continue to sell combination products containing the drug.
"West Virginia’s stop-sale system continues to prove its value in the fight against methamphetamine," West Virginia Retailers Association president Bridget Lambert said. "These most recent results again emphasize the importance of giving this new system time to work. Its benefit to retailers and to law enforcement cannot be overstated."